Clearwater Paper Corp. 10-Q Summary: Q2 2024
Business Context and Reporting Period
This report covers the quarterly period ended June 30, 2024. Clearwater Paper Corporation operates in two segments: Pulp and Paperboard and Consumer Products. The quarter was defined by two major strategic transactions: the acquisition of a paperboard manufacturing facility in Augusta, Georgia (closed May 1, 2024), and the subsequent announcement of an agreement to sell the Consumer Products (tissue) division to Sofidel America Corp. for approximately $1.06 billion.
Key Financial Metrics
| Metric | Q2 2024 | Q2 2023 | YTD 2024 | YTD 2023 |
|---|---|---|---|---|
| Net Sales | $586.4 million | $524.6 million | $1,082.6 million | $1,050.0 million |
| Net Income (Loss) | $(25.8) million | $29.7 million | $(8.6) million | $53.5 million |
| Diluted EPS | $(1.55) | $1.75 | $(0.52) | $3.15 |
| Adjusted EBITDA | $35.3 million | $71.5 million | $96.8 million | $137.2 million |
| Operating Cash Flow | $21.1 million | $46.0 million | $80.3 million | $36.9 million |
| Total Debt | $1,143.0 million | $463.1 million | $1,143.0 million | $463.1 million |
| Cash & Equivalents | $39.6 million | $41.7 million | $39.6 million | $41.7 million |
Material Changes vs. Prior Period
- Profitability Decline: The company reported a net loss of $25.8 million in Q2 2024, a reversal from a $29.7 million profit in Q2 2023. This was driven by a $17.0 million charge for "Other operating charges" (acquisition/divestiture costs and integration) and increased interest expense ($16.0 million vs. $7.5 million).
- Segment Performance:
- Pulp and Paperboard: Sales increased 22.5% to $333.6 million due to the Augusta acquisition. However, operating income turned negative at $(12.2) million (vs. $42.0 million prior year) due to lower sales prices, maintenance outages, and integration costs.
- Consumer Products: Sales remained flat at $252.8 million. Operating income improved to $27.4 million (vs. $25.0 million) driven by lower raw material costs and higher volumes.
- Balance Sheet Expansion: Total assets increased to $2.48 billion from $1.67 billion, primarily due to the $708.2 million Augusta acquisition. Long-term debt more than doubled to $1.14 billion to fund the acquisition.
Guidance, Outlook, and Risks
- Divestiture: The company expects to close the sale of its Consumer Products division in Q4 2024, anticipating net proceeds of approximately $850 million to de-lever the balance sheet.
- Capital Expenditures: Management expects cash paid for capital expenditures to be between $120 million and $140 million for the full year 2024.
- Debt Covenants: The company is currently in compliance with its Term Credit Agreement and ABL Credit Agreement. Covenants include a maximum consolidated leverage ratio (currently 4.50x, stepping down to 4.00x) and a minimum current ratio of 1.25x.
- Risks: Key risks include the failure to obtain regulatory approval for the tissue divestiture, integration challenges with the Augusta facility, and continued pricing pressures in the paperboard market.
Investor Verification Checklist
- Divestiture Closing: Verify the timeline and regulatory status of the $1.06 billion sale of the tissue business to Sofidel.
- Debt Servicing: Monitor the company's ability to service the increased debt load ($1.14 billion) and meet leverage covenants prior to the divestiture closing.
- Integration Costs: Track the realization of synergies and cost savings from the Augusta acquisition against the $14.5 million in acquisition-related costs incurred YTD.
- Pricing Trends: Assess the sustainability of paperboard sales prices, which declined 13.9% year-over-year in Q2.